Clinical Trial Update: Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating AVTR101 for sarcopenia in the elderly was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcopenia

Drugs mentioned

• AVTR101

Snippet

Sponsor: Aventi Biotechnology Inc. | Conditions: Sarcopenia | Phase 2 | Status: TERMINATED